期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 69, 期 1, 页码 59-65出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2010.09.005
关键词
QuantiFERON-TB Gold In-Tube; IGRA; Tuberculosis; HIV
资金
- Fundacion para la Investigacion del SIDA en Espana (FIPSE) [FIPSE 24589/06]
- Ministerio de Ciencia e Innovacion
- Instituto de Salud Carlos III
- European Development Regional Fund
- Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]
- University of Barcelona (Beca de Formacio en la Recerca i la Docencia)
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- Inverness Medical Iberica
This study evaluated the QuantiFERON-TB Gold In-Tube (QFT-GIT; Cellestis, Carnegie, Australia) test and the tuberculin skin test (TST) for the detection of latent tuberculosis infection (LTBI) in HIV-infected adults. One hundred thirty-five HIV-seropositive persons and 135 controls underwent TST and QFT-GIT. HIV-infected patients who gave a positive result on either test were offered chemoprophylaxis. The prevalence of LTBI was 6.7% by TST and 9.6% by QFT-GIT (P = 0.3) in HIV-seropositive subjects, and 34.8% by TST and 21.5% by QFT-GIT (P = 0.02) among controls. TST reactivity declined sharply as CD4(+) cells fell (15.8%, 10.3%, and 0% for >500, 301-500 and <= 300 CD4(+) cells/mm(3), respectively; P = 0.002). A less pronounced fall occurred with QFT-GIT (15.8%, 13.8%, and 0% for >500, 301-500, and <100 CD4(+) cells/mm(3), respectively; P = 0.03). No cases of tuberculosis occurred during follow-up (0.26 per 100 person-years). Simultaneous testing with TST and QFT-GIT for targeting of chemoprophylaxis, early in the course of HIV infection, might minimize the risk of tuberculosis in these patients. (C) 2011 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据